XERAVA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 Oct 2025)
What this means for you
Registered since 24 Sept 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87782461
- Registration number
- 5869102
- Mark type
- Stylized text
- Filed
- 02 Feb 2018
- Published for opposition
- 21 Aug 2018
- Registered
- 24 Sept 2019
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, antibiotics indicated for the treatment of infections; the aforementioned not for the treatment of rheumatoid arthritis or psoriasis
Owner
- Tetraphase Pharmaceuticals, Inc., Waltham, MA, US
- Tetraphase Pharmaceuticals, Inc., Watertown, MA, US
- Tetraphase Pharmaceuticals, Inc., Watertown, MA, US
Prosecution history
- 03 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 May 2025 — TEAS SECTION 8 & 15 RECEIVED
- 24 Sept 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Sept 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Sept 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Sept 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Sept 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Sept 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Sept 2019 — REGISTERED-PRINCIPAL REGISTER
- 22 Aug 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Aug 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Aug 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Jul 2019 — USE AMENDMENT FILED